CONCLUSIONS: Residual angina is common (>40%) following anatomic complete revascularization for chronic coronary disease and is associated with reduced quality of life and greater antianginal medication use but no increase in death.
Read more...CONCLUSIONS: PASCAL M-TEER resulted in similar technical success rates and 1-year mortality across sexes, despite females achieving an optimal result less frequently, due to higher postprocedural gradients. MR reduction to mild or less was the primary determinant of improved survival,[…]
Read more...The management of asymptomatic severe aortic stenosis (AS) has traditionally relied on watchful waiting until the onset of symptoms or left ventricular dysfunction. However, the FDA's approval of transcatheter aortic valve replacement (TAVR) with the Sapien 3 platform in May[…]
Read more...Read more...
CONCLUSIONS: Real-world DCB use is increasing rapidly in the United States, driven by use in ISR lesions but also with growth among non-ISR lesions.
Read more...CONCLUSIONS: Clustering analysis identified 3 distinct SMR phenotypes that were validated across 2 landmark M-TEER trials. Outcomes following M-TEER are better predicted by multidimensional patient phenotypes integrating CD, surgical risk, and comorbidity burden than by any single domain alone and[…]
Read more...CONCLUSIONS: TF TMVR in patients with complex anatomies achieved a high rate of implantation success, low 30-day mortality, and no significant residual MR.
Read more...Read more...
CONCLUSIONS: In this large real-world cohort from two publicly funded healthcare systems, many patients with degenerative MR were referred late for surgery, and early intervention was rare. While in-hospital mortality was low overall, outcomes varied across subgroups. MV repair declined[…]
Read more...CONCLUSIONS AND RELEVANCE: Among Medicare beneficiaries, women constituted a progressively declining proportion of patients treated with TAVI, experienced more periprocedural complications, and demonstrated modestly better long-term survival compared with men. Further work is needed to understand factors influencing these trends[…]
Read more...
1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
Please e-mail us if you would
like more information:
info@crf.org
© 2026, Cardiovascular Research Foundation®. All rights reserved.
